ArticleBMC nephrology2025
Analysis of prognostic risk factors in critically ill elderly patients with sepsis-associated acute kidney injury.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Sepsis-Associated Acute Kidney Injury and 28-Day Mortality in Critically Ill Patients with Sepsis: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- The Relationship Between the Pan-Immune-Inflammation Value (PIV) and Mortality in Elderly Critically Ill Patients with Sepsis: A Single-Centre Retrospective Study.Journal of clinical medicine · 2026Article
- [Special ethical aspects in older intensive care patients].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2026Article
- Nomogram analysis of factors associated with prognosis in patients with sepsis-associated acute kidney injury: a case-control study based on LASSO regression.Frontiers in medicine · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTo investigate the risk factors influencing the prognosis of critically ill elderly patients with sepsis-associated acute kidney injury (SA-AKI).
methodsThis retrospective study analyzed data from the Medical Information Mart for Intensive Care (MIMIC) Ⅳ database collected between 2008 and 2019. A total of 3,338 elderly patients with SA-AKI were included and categorized into a survival group (n = 2,448) and a death group (n = 898) based on 28-day mortality outcomes. Least Absolute Shrinkage and Selection Operator (LASSO) regression was utilized to identify potential predictors, and multivariate Cox regression was employed to analyze independent risk factors associated with 28-day mortality in elderly patients with SA-AKI.
resultsThe 28-day mortality rate in elderly patients with SA-AKI was 26.9%. Multivariate Cox regression analysis revealed that age ≥ 76 years (Hazard Ratio[HR] = 1.392, 95% Confidence Interval[CI] 1.212-1.598, P < 0.001), creatinine ≥ 1.5 mg/dL (HR = 1.216, 95%CI 1.037-1.427, P = 0.016), urea-to-creatinine ratio (UCR) ≥ 20 (HR = 1.668, 95%CI 1.441-1.931, P < 0.001), liver disease (HR = 1.292, 95%CI 1.059-1.575, P = 0.011), renal replacement therapy (HR = 1.476, 95%CI 1.160-1.879, P = 0.002), use of norepinephrine (HR = 1.624, 95%CI 1.390-1.896, P < 0.001), dobutamine (HR = 1.644, 95%CI 1.225-2.206, P < 0.001), dopamine (HR = 1.260, 95%CI 1.008-1.576, P = 0.042), and vasopressin (HR = 1.708, 95%CI 1.430-2.041, P < 0.001) were significant risk factors for 28-day mortality in elderly patients with SA-AKI. In contrast, epinephrine use was associated with lower mortality (HR = 0.553, 95%CI 0.417-0.734, P < 0.001).
conclusionsElderly SA-AKI patients have a high short-term mortality. Advanced age, renal impairment, liver disease, renal replacement therapy, and the use of several vasoactive drugs were associated with poor outcomes, while the potential benefit of epinephrine requires further validation. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.